Mercer Global Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.26M Buy
51,855
+4,886
+10% +$340K ﹤0.01% 964
2025
Q4
$3.12M Buy
46,969
+21,411
+84% +$1.38M ﹤0.01% 910
2025
Q3
$1.72M Buy
25,558
+2,249
+10% +$178K ﹤0.01% 1101
2025
Q2
$2.03M Buy
23,309
+692
+3% +$54.2K ﹤0.01% 877
2025
Q1
$1.54M Buy
22,617
+2,272
+11% +$185K ﹤0.01% 932
2024
Q4
$1.58M Buy
20,345
+10,666
+110% +$790K ﹤0.01% 907
2024
Q3
$639K Sell
9,679
-327
-3% -$26.9K ﹤0.01% 1211
2024
Q2
$1.13M Sell
10,006
-2,064
-17% -$261K ﹤0.01% 916
2024
Q1
$1.67M Buy
12,070
+2,363
+24% +$297K ﹤0.01% 772
2023
Q4
$1.21M Buy
9,707
+2,734
+39% +$279K ﹤0.01% 905
2023
Q3
$651K Sell
6,973
-1,312
-16% -$148K ﹤0.01% 1121
2023
Q2
$1.06M Sell
8,285
-6,144
-43% -$743K ﹤0.01% 930
2023
Q1
$1.68M Sell
14,429
-551
-4% -$61.7K 0.01% 729
2022
Q4
$1.7M Buy
14,980
+787
+6% +$86.4K 0.01% 721
2022
Q3
$1.14M Buy
14,193
+364
+3% +$30.8K 0.01% 797
2022
Q2
$1.03M Buy
13,829
+1,453
+12% +$133K 0.01% 828
2022
Q1
$1.58M Buy
12,376
+856
+7% +$93.6K 0.01% 718
2021
Q4
$1.55M Buy
11,520
+1,172
+11% +$168K 0.01% 714
2021
Q3
$1.42M Buy
10,348
+1,560
+18% +$197K 0.01% 742
2021
Q2
$938K Buy
8,788
+16
+0.2% +$1.54K 0.01% 867
2021
Q1
$788K Buy
8,772
+5,528
+170% +$519K 0.01% 883
2020
Q4
$300K Buy
3,244
+48
+2% +$4.29K ﹤0.01% 1067
2020
Q3
$329K Buy
3,196
+20
+0.6% +$2.09K ﹤0.01% 924
2020
Q2
$322K Buy
+3,176
New +$284K 0.01% 827

Other funds holding DXCM

Mercer Global Advisors's DXCM Position: Q1 2026 in Review

Mercer Global Advisors increased its DexCom (DXCM) stake by 10% in Q1 2026, buying an estimated $340K and bringing the position to 51,855 shares worth $3.26M. The position accounts for ﹤0.01% of the portfolio, ranked #964.

Mercer Global Advisors first reported a position in DXCM in Q2 2020 and has held it in 24 quarters since. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Mercer Global Advisors held 51,855 shares of DexCom worth $3.26M as of Q1 2026.
  • Mercer Global Advisors bought 4,886 DexCom shares in Q1 2026, an estimated $340K.
  • DexCom made up ﹤0.01% of Mercer Global Advisors's portfolio in Q1 2026, its #964 holding.
  • Mercer Global Advisors first reported a position in DexCom in Q2 2020 and has held it in 24 quarters since.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.